Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: A systematic review and meta-analysis
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2020.05.08.20095968: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable Exclusion criteria: Studies excluded if COVID-19 was reported among pregnant women or children (aged <18 years) and written in languages other than English. Table 2: Resources
Software and Algorithms Sentences Resources Search strategy: Four databases: Medline, Web of Science, Scopus, and CINAHL were searched, concluded on May 01, 2020, using pre-specified search strategies for each database. Medlinesuggested: (MEDLINE, RRID:SCR_002185)Additional searches were conducted using the reference list of the selected studies, relevant journal websites, and … SciScore for 10.1101/2020.05.08.20095968: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable Exclusion criteria: Studies excluded if COVID-19 was reported among pregnant women or children (aged <18 years) and written in languages other than English. Table 2: Resources
Software and Algorithms Sentences Resources Search strategy: Four databases: Medline, Web of Science, Scopus, and CINAHL were searched, concluded on May 01, 2020, using pre-specified search strategies for each database. Medlinesuggested: (MEDLINE, RRID:SCR_002185)Additional searches were conducted using the reference list of the selected studies, relevant journal websites, and renowned pre-print servers (medRxiv, bioRxiv, SSRN). bioRxivsuggested: (bioRxiv, RRID:SCR_003933)Stata software version 15.1 (StataCorp. Statasuggested: (Stata, RRID:SCR_012763)StataCorpsuggested: (Stata, RRID:SCR_012763)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:Strengths and limitations: This study has several strengths and limitations that should be reported. To our knowledge, this is the first of its kind that summarizes all morbidities among COVID-19 patients that lead to death. Moreover, morbidities reported among COVID-19 patients were classified into board groups based on their characteristics, and the likelihood of death was estimated separately for each group. This evidence informs healthcare providers about the risk of death among COVID-19 patients with different groups of pre-existing morbidities. Thus, they will be able to take precautionary measures early targeting to prevent deaths. However, this study reported the odds of death for COVID-19 patients with one pre-existing morbidity only. Many COVID-19 patients may have multi-morbidities (COVID-19 with pre-existing two or more morbidities) and a higher risk of death. However, the studies included in this review considered each morbidity separately; for instance, if COVID-19 patients had both hypertension and diabetes, they were included in both groups. None of the included studies considered COVID-19 with two or more morbidities together; therefore, we failed to provide the likelihood of deaths for COVID-19 patients with two or more pre-existing morbidities. Moreover, the likelihoods presented in this study were mostly unadjusted (31 of the 36 articles included) calculated from the extracted raw data. This may overestimate or underestimate the actual likelihood of deaths...
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
